Klaus W. Wagner
2020
In 2020, Klaus W. Wagner earned a total compensation of $976.8K as Chief Medical Officer at Inhibrx, a 89% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,074 |
|---|---|
| Option Awards | $376,682 |
| Salary | $396,000 |
| Other | $6,000 |
| Total | $976,756 |
Wagner received $396K in salary, accounting for 41% of the total pay in 2020.
Wagner also received $198.1K in non-equity incentive plan, $376.7K in option awards and $6K in other compensation.
Rankings
In 2020, Klaus W. Wagner's compensation ranked 8,739th out of 13,090 executives tracked by ExecPay. In other words, Wagner earned more than 33.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,739 out of 13,090 | 33rd |
Division Manufacturing | 3,724 out of 5,624 | 34th |
Major group Chemicals And Allied Products | 1,505 out of 2,257 | 33rd |
Industry group Drugs | 1,311 out of 1,957 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 306 out of 411 | 26th |
Source: SEC filing on April 28, 2021.
Wagner's colleagues
We found three more compensation records of executives who worked with Klaus W. Wagner at Inhibrx in 2020.